AASLD American Association for the Study Liver Diseases
AFP Alphafetoprotein
AIDS Acquired Immune Deficiency Syndrome
ALP Alkaline Phosphatase
ALT Alanine Aminotransferase
ART Anti-Retroviral Therapy
AST Aspartate Aminotransferase
CAM Complementary and Alternative Medicines
DAA Direct-Acting Antiviral drugs
DNA Deoxyribonucleic Acid
EASL European Association for the Study of the Liver
EHRN Eurasian Harm Reduction Network
EIA Enzyme immunoassay
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
ESLD End Stage Liver Disease
GGT Gamma Glutamyl Transferase
HAART Highly Active Anti-Retroviral Therapy
HAV Hepatitis A Virus
HBV Hepatitis B Virus
HCC Hepatocellular Carcinoma
HCV Hepatitis C Virus
HDV Hepatitis D Virus
HEV Hepatitis E Virus
HIV Human Immunodeficiency Virus
IFN Interferon
IHRA International Harm Reduction Association
LDCs Least Developed Countries
LFT Liver Function Test
MTCT Mother To Child Transmission
NSP Needle and Syringe Programme
OST Opioid Substitution Treatment
PCR Polymerase Chain Reaction
PEG-IFN Pegylated Interferon
PLWHCV People Living With HCV
PLWHIV People Living With HIV
PT Prothrombin Time
PWID People Who Inject Drugs
RIBA Recombinant Immunoblot Assay
RNA Ribonucleic Acid
RT-PCR Reverse Transcription Polymerase Chain Reaction
TMA Transcription-Mediated Amplification
RBV Ribavirin
STI Sexually Transmitted Infection
SVR Sustained Viral Response
TRIPS Trade-Related Aspects of Intellectual Property Rights
WHO World Health Organisation
WTO World Trade Organisation
index ¦ top